Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

A Nanoparticle-Based Approach for the Detection of Extracellular Vesicles.

Islam MK, Syed P, Lehtinen L, Leivo J, Gidwani K, Wittfooth S, Pettersson K, Lamminmäki U.

Sci Rep. 2019 Jul 11;9(1):10038. doi: 10.1038/s41598-019-46395-2.

2.

Free PAPP-A as a biomarker: heparin-induced release is not related to coronary atherosclerotic burden.

Tuunainen E, Maaniitty T, Knuuti J, Pettersson K, Wittfooth S, Saraste A.

Clin Chem Lab Med. 2019 Jun 26;57(7):e155-e158. doi: 10.1515/cclm-2018-1062. No abstract available.

PMID:
30412462
3.

Potentially pathogenic circulating autoantibodies to cardiac troponin are present in hemodialysis patients.

Jefferies HJ, Tertti R, Wittfooth S, Burton JO, Metsärinne K, Pettersson K, McIntyre CW.

Hemodial Int. 2017 Oct;21(4):519-523. doi: 10.1111/hdi.12514. Epub 2016 Nov 20.

PMID:
27866393
4.

Integrated Acoustic Separation, Enrichment, and Microchip Polymerase Chain Reaction Detection of Bacteria from Blood for Rapid Sepsis Diagnostics.

Ohlsson P, Evander M, Petersson K, Mellhammar L, Lehmusvuori A, Karhunen U, Soikkeli M, Seppä T, Tuunainen E, Spangar A, von Lode P, Rantakokko-Jalava K, Otto G, Scheding S, Soukka T, Wittfooth S, Laurell T.

Anal Chem. 2016 Oct 4;88(19):9403-9411. Epub 2016 Sep 14.

PMID:
27264110
5.

Ready to use dry-reagent PCR assays for the four common bacterial pathogens using switchable lanthanide luminescence probe system.

Lehmusvuori A, Soikkeli M, Tuunainen E, Seppä T, Spangar A, Rantakokko-Jalava K, von Lode P, Karhunen U, Soukka T, Wittfooth S.

J Microbiol Methods. 2015 Nov;118:64-9. doi: 10.1016/j.mimet.2015.08.022. Epub 2015 Sep 3.

PMID:
26342433
6.

Elevated serum free pregnancy-associated plasma protein-A independently predicts mortality in haemodialysis patients but is not associated with recurrent haemodialysis-induced ischaemic myocardial injury.

Jefferies HJ, Tertti R, Wittfooth S, Burton JO, Metsärinne K, Pettersson K, McIntyre CW.

Nephron. 2015;129(3):171-8. doi: 10.1159/000369557. Epub 2015 Mar 6.

PMID:
25766334
7.

Novel sensitive cardiac troponin I immunoassay free from troponin I-specific autoantibody interference.

Savukoski T, Jacobino J, Laitinen P, Lindahl B, Venge P, Ristiniemi N, Wittfooth S, Pettersson K.

Clin Chem Lab Med. 2014 Jul;52(7):1041-8. doi: 10.1515/cclm-2013-1044.

PMID:
24615485
8.

Autoantibody prevalence with an improved immunoassay for detecting cardiac troponin-specific autoantibodies.

Savukoski T, Ilva T, Lund J, Porela P, Ristiniemi N, Wittfooth S, Pettersson K.

Clin Chem Lab Med. 2014 Feb;52(2):273-9. doi: 10.1515/cclm-2013-0310.

PMID:
24088614
9.

Epitope specificity and IgG subclass distribution of autoantibodies to cardiac troponin.

Savukoski T, Twarda A, Hellberg S, Ristiniemi N, Wittfooth S, Sinisalo J, Pettersson K.

Clin Chem. 2013 Mar;59(3):512-8. doi: 10.1373/clinchem.2012.194860. Epub 2013 Jan 3.

10.

Troponin-specific autoantibody interference in different cardiac troponin I assay configurations.

Savukoski T, Engström E, Engblom J, Ristiniemi N, Wittfooth S, Lindahl B, Eggers KM, Venge P, Pettersson K.

Clin Chem. 2012 Jun;58(6):1040-8. doi: 10.1373/clinchem.2011.179226. Epub 2012 Apr 9.

11.

Studies on the effects of heparin products on pregnancy-associated plasma protein A.

Wittfooth S, Tertti R, Lepäntalo M, Porela P, Qin QP, Tynjälä J, Inkinen O, Perttilä J, Airaksinen KE, Pettersson K.

Clin Chim Acta. 2011 Jan 30;412(3-4):376-81. doi: 10.1016/j.cca.2010.11.024. Epub 2010 Nov 19.

PMID:
21094153
12.

Autoantibodies to cardiac troponin in acute coronary syndromes.

Lindahl B, Venge P, Eggers KM, Gedeborg R, Ristiniemi N, Wittfooth S, Pettersson K.

Clin Chim Acta. 2010 Nov 11;411(21-22):1793-8. doi: 10.1016/j.cca.2010.08.005. Epub 2010 Aug 12.

PMID:
20708608
13.

Free vs total pregnancy-associated plasma protein A (PAPP-A) as a predictor of 1-year outcome in patients presenting with non-ST-elevation acute coronary syndrome.

Lund J, Wittfooth S, Qin QP, Ilva T, Porela P, Pulkki K, Pettersson K, Voipio-Pulkki LM.

Clin Chem. 2010 Jul;56(7):1158-65. doi: 10.1373/clinchem.2009.136960. Epub 2010 May 6.

14.

Intravenous administration of low molecular weight and unfractionated heparin elicits a rapid increase in serum pregnancy-associated plasma protein A.

Tertti R, Wittfooth S, Porela P, Airaksinen KE, Metsärinne K, Pettersson K.

Clin Chem. 2009 Jun;55(6):1214-7. doi: 10.1373/clinchem.2008.108738. Epub 2009 Mar 26.

15.

Autoantibodies to cardiac troponin associate with higher initial concentrations and longer release of troponin I in acute coronary syndrome patients.

Pettersson K, Eriksson S, Wittfooth S, Engström E, Nieminen M, Sinisalo J.

Clin Chem. 2009 May;55(5):938-45. doi: 10.1373/clinchem.2008.115469. Epub 2009 Mar 5.

16.

Performance of immunofluorometric point-of-care assays for free pregnancy-associated plasma protein A detection in whole blood samples.

Wittfooth S, Qin QP, Pettersson K.

Clin Chem Lab Med. 2008;46(1):18-20. No abstract available.

PMID:
17663635
17.

Measurement and clinical significance of circulating PAPP-A in ACS patients.

Qin QP, Wittfooth S, Pettersson K.

Clin Chim Acta. 2007 May 1;380(1-2):59-67. Epub 2007 Feb 27. Review.

PMID:
17376420
18.

Present and future biochemical markers for detection of acute coronary syndrome.

Eriksson S, Wittfooth S, Pettersson K.

Crit Rev Clin Lab Sci. 2006;43(5-6):427-95. Review.

PMID:
17043039
19.

Immunofluorometric point-of-care assays for the detection of acute coronary syndrome-related noncomplexed pregnancy-associated plasma protein A.

Wittfooth S, Qin QP, Lund J, Tierala I, Pulkki K, Takalo H, Pettersson K.

Clin Chem. 2006 Sep;52(9):1794-801. Epub 2006 Jun 29.

Supplemental Content

Loading ...
Support Center